Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02365870 · ClinicalTrials.gov registry record · Phase 4
Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment
A Phase 4 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT02365870: Clinical Trial Phase 4 study, sponsored by Johns Hopkins University.
NCT02365870 is a Phase 4 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 4 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02365870, a Phase 4 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of the rotigotine transdermal patch in reducing anxiety in people with Parkinson's disease.
Primary Outcome
The main outcome measure for this study was change in anxiety symptom severity over the course of the study. Anxiety severity was measured using the Hamilton Anxiety Rating Scale (HARS).The HARS is a 14-item questionnaire, with each item assigned a score ranging from 0 ("not present") to 4 ("severe"). The total score of this scale ranges from 0 to 56, with scores greater than 17 indicating mild severity, scores between 18 and 24 indicating mild to moderate severity and scores greater than 25 ind
Interventions
- DRUG placebo
- DRUG rotigotine transdermal patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-07 |
| Phase | Phase 4 |
Why NCT02365870 stopped before completion
NCT02365870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02365870 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02365870 about?
NCT02365870 is a clinical study titled "Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment". This study will evaluate the effectiveness of the rotigotine transdermal patch in reducing anxiety in people with Parkinson's disease.
What is the current status of trial NCT02365870?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2016-08. Estimated completion is 2019-07.
What interventions are being tested in trial NCT02365870?
The interventions under investigation include: placebo (DRUG), rotigotine transdermal patch (DRUG).
Who is sponsoring clinical trial NCT02365870?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02365870's enrollment target sits among peer trials
4 1994th of 2000 higher than 6 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia